Likarda
Latest round
- Series A
Last raised
- Aug 2017
Total raised
- $4M
Investors
- 1
About Likarda
Likarda, LLC specializes in developing innovative solutions for cell therapy delivery.Likarda specializes in the development of innovative cell therapy delivery systems, primarily through its proprietary Core Shell Spherification® (CSS) technology. This unique platform is designed to improve the potency and efficacy of various cell therapies by utilizing customizable hydrogels that encapsulate therapeutic cells. The hydrogels protect cells from immune system attacks and ensure they remain localized at target sites within the body, enhancing treatment outcomes for chronic and fatal diseases.Likarda's revenue generation model is primarily centered on partnerships and collaborations with biotechnology and pharmaceutical companies, which involve contract research agreements and customized development projects. The company offers bespoke hydrogel products tailored to specific therapeutic applications. Transactions are structured based on project scope, including milestone payments aligned with research and development phases. Flagship products, such as their specialized hydrogel formulations, are integral to these collaborations, providing unique solutions designed to enhance the effectiveness of therapies.Likarda is focused on expanding its product offerings and entering new markets. The company is developing additional hydrogel products aimed at addressing specific therapeutic challenges, with anticipated releases aligned with ongoing research collaborations.00 mn from Series A will support these initiatives, enhancing their capacity for growth in North America, Europe, and Asia, with a strategic focus on increasing market share by 2025.
Who invested in Likarda
1 investor across 1 round
See all investors in Likarda
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 28, 2017
Amount
$4M
Investors
Questions about Likarda
Who invested in Likarda?
Likarda has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Likarda raised?
Likarda has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Likarda last raise money?
Likarda's most recent round on record is a Series A, in Aug 2017.
What does Likarda do?
Likarda, LLC specializes in developing innovative solutions for cell therapy delivery.
Where is Likarda headquartered?
Likarda is headquartered in Kansas City, US.
Which VCs invest in companies like Likarda?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Likarda's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Likarda? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.